- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ImmuneOncia Therapeutics Inc (424870)
ImmuneOncia Therapeutics Inc stock price live, this page displays KQ 424870 stock exchange data. View the 424870 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ImmuneOncia Therapeutics Inc real time stock price chart below.
What Is the ImmuneOncia Therapeutics Inc Stock Price Today?
The ImmuneOncia Therapeutics Inc stock price today is 5,600.00.
What Is the Stock Symbol for ImmuneOncia Therapeutics Inc?
The stock symbol for ImmuneOncia Therapeutics Inc is "424870."
What Stock Exchange Does ImmuneOncia Therapeutics Inc Trade On?
ImmuneOncia Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is ImmuneOncia Therapeutics Inc a Good Stock to Buy?
Determining whether ImmuneOncia Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 424870 quote. (ISIN: KR7424870004)
What Is the ImmuneOncia Therapeutics Inc Stock Price Today?
The ImmuneOncia Therapeutics Inc stock price today is 5,600.00.
What Is the Stock Symbol for ImmuneOncia Therapeutics Inc?
The stock symbol for ImmuneOncia Therapeutics Inc is "424870."
What Stock Exchange Does ImmuneOncia Therapeutics Inc Trade On?
ImmuneOncia Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is ImmuneOncia Therapeutics Inc a Good Stock to Buy?
Determining whether ImmuneOncia Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 424870 quote. (ISIN: KR7424870004)
KOSDAQ
Currency in KRW
5,600.00
-100.00(-1.75%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5,450.00
5,730.00
52 wk Range
4,455.00
8,300.00
424870 Scorecard
Full Analysis
Significant return over the last week
424870 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5,450.005,730.00
52 wk Range
4,455.008,300.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
424870 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
ImmuneOncia Therapeutics Inc Company Profile
ImmuneOncia Therapeutics, Inc., an immuno-oncology-centric biopharmaceutical company, develops immuno-oncology drugs for the treatment of cancer. It develops IMC-001, a human monoclonal antibody of the IgG1 type that targets PD-L1 an immunotherapy for cancer, which is in Phase II clinical trial for the treatment of NK/T cell lymphoma and solid cancer patients with high tumor mutation burden; and IMC-002, a human monoclonal antibody of the IgG4 type targeting human CD47, which is in Phase I a clinical trial for the treatment of solid cancers, such as triple-negative breast cancer, hepatocellular carcinoma, and bile duct cancer. The company also develops non clinical products, which includes IMC-201, a CD47xPD-L1 dual antibody based immunotherapy; and IMC-202, a PD-L1xTIGIT dual antibody based immunotherapy. The company was incorporated in 2016 and is headquartered in Yongin-si, South Korea. ImmuneOncia Therapeutics, Inc. operates as a subsidiary of Yuhan Corporation.
Compare 424870 to Peers and Sector
Metrics to compare | 424870 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship424870PeersSector | |
|---|---|---|---|---|
P/E Ratio | −72.8x | −15.6x | −0.5x | |
PEG Ratio | 0.46 | −0.04 | 0.00 | |
Price/Book | - | 4.0x | 2.6x | |
Price / LTM Sales | 632.3x | 47.7x | 3.1x | |
Upside (Analyst Target) | - | 118.3% | 46.1% | |
Fair Value Upside | Unlock | 5.3% | 6.9% | Unlock |
People Also Watch
FAQ
What Is the ImmuneOncia Therapeutics (424870) Stock Price Today?
The ImmuneOncia Therapeutics stock price today is 5,600.00
What Stock Exchange Does ImmuneOncia Therapeutics Trade On?
ImmuneOncia Therapeutics is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for ImmuneOncia Therapeutics?
The stock symbol for ImmuneOncia Therapeutics is "424870."
What Is the ImmuneOncia Therapeutics Market Cap?
As of today, ImmuneOncia Therapeutics market cap is 413.87B.
What Is ImmuneOncia Therapeutics's Earnings Per Share (TTM)?
The ImmuneOncia Therapeutics EPS (TTM) is -101.00.
From a Technical Analysis Perspective, Is 424870 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has ImmuneOncia Therapeutics Stock Split?
ImmuneOncia Therapeutics has split 0 times.
How Many Employees Does ImmuneOncia Therapeutics Have?
ImmuneOncia Therapeutics has 0 employees.
What is the current trading status of ImmuneOncia Therapeutics (424870)?
As of 11 July 2025, ImmuneOncia Therapeutics (424870) is trading at a price of 5,600.00, with a previous close of 5,700.00. The stock has fluctuated within a day range of 5,450.00 to 5,730.00, while its 52-week range spans from 4,455.00 to 8,300.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.